nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy
|
Maio, Michele |
|
2018 |
68 |
1 |
p. 1-9 |
artikel |
2 |
β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress
|
Qiao, Guanxi |
|
2018 |
68 |
1 |
p. 11-22 |
artikel |
3 |
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells
|
Tomasicchio, Michele |
|
2018 |
68 |
1 |
p. 71-83 |
artikel |
4 |
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
|
Weinstein, Aliyah M. |
|
2018 |
68 |
1 |
p. 109-120 |
artikel |
5 |
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer
|
Jiang, Qi |
|
2018 |
68 |
1 |
p. 45-56 |
artikel |
6 |
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017
|
Maio, Michele |
|
2018 |
68 |
1 |
p. 151-158 |
artikel |
7 |
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
|
Ruiu, Roberto |
|
2018 |
68 |
1 |
p. 131-141 |
artikel |
8 |
Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
|
Zhang, Wen |
|
2018 |
68 |
1 |
p. 121-130 |
artikel |
9 |
Prediction of neoepitopes from murine sequencing data
|
Bjerregaard, Anne-Mette |
|
2018 |
68 |
1 |
p. 159-161 |
artikel |
10 |
Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma
|
Wang, Wei |
|
2018 |
68 |
1 |
p. 85-95 |
artikel |
11 |
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics
|
Fortis, Sotirios P. |
|
2018 |
68 |
1 |
p. 57-70 |
artikel |
12 |
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
|
Pistillo, Maria Pia |
|
2018 |
68 |
1 |
p. 97-107 |
artikel |
13 |
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
|
Lee, Jeong-Hoon |
|
2018 |
68 |
1 |
p. 23-32 |
artikel |
14 |
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology
|
Di Giacomo, Anna Maria |
|
2018 |
68 |
1 |
p. 143-150 |
artikel |
15 |
TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression
|
Gershkovitz, Maya |
|
2018 |
68 |
1 |
p. 33-43 |
artikel |